-

PNR Stockholders Have Rights – If You Lost Money Investing in Pentair plc Contact Robbins LLP for Information About Recovering Your Losses

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Pentair plc (NYSE: PNR) securities between April 28, 2026 and July 14, 2026 (the "Class Period"). Pentair provides various water solutions, such as filtration, water supply pumps, and fluid treatment products.

PNR Stockholders Have Rights – If You Lost Money Investing in Pentair plc Contact Robbins LLP for Information About Recovering Your Losses

Share

The lawsuit alleges that Pentair misled investors regarding the destocking of its inventory in the Pool channel.

Investors who suffered losses during the Class Period may have legal rights and should contact Robbins LLP prior to October 2, 2026, for information about seeking appointment as lead plaintiff.

Listen to our podcast.

Why Was Pentair Sued?

According to the complaint, Pentair misled investors regarding the destocking of inventory in the Pool channel, which adversely affected the Company's sales and operating income.

According to the complaint, defendants failed to disclose that:

(1) there was significant destocking of inventory in the Pool channel;
(2) as a result, the Company’s sales and operating income were adversely affected; and
(3) as a result, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Why Did PNR Stock Collapse?

On July 14, 2026, after the market closed, Pentair released its preliminary second quarter 2026 financial results, disclosing that “the [C]ompany estimates that the destocking of inventory in the Pool channel negatively impacted Pool segment sales by approximately $170 million and Pool segment income by approximately $105 million.” As a result, second quarter 2026 sales were expected to be “down 17 percent versus the prior guide of approximately 1 percent” and full year 2026 “[s]ales are expected to be down approximately 4 percent to 7 percent versus prior guide of up 2 percent to 4 percent[.]” The Company also announced the departure of its Chief Financial Officer, effective immediately.

On this news, Pentair’s stock price fell $11.35, or 15%, to close at $64.33 per share on July 15, 2026.

Who May Be Eligible to Participate in the Pentair Class Action?

The lawsuit seeks to represent investors who purchased or otherwise acquired Pentair plc (PNR) securities during the applicable Class Period. If you purchased Pentair stock during this period and suffered investment losses, you may have rights under the federal securities laws.

What Is a Lead Plaintiff?

The lead plaintiff is the investor appointed by the court to represent the interests of the proposed class throughout the litigation. Investors do not have to serve as lead plaintiff to potentially share in any recovery if the lawsuit is successful.

Shareholders interested in seeking appointment as lead plaintiff must submit their papers with the court by October 2, 2026.

Does it cost anything to participate?

No. Robbins LLP represents investors on a contingency fee basis.

Contact Robbins LLP

Investors seeking additional information about the Pentair securities class action may submit an inquiry through Robbins LLP's website, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

About Robbins LLP

A recognized leader in shareholder rights litigation, Robbins LLP has helped restore more than $1 billion in value to shareholders and secured some of the largest recoveries in shareholder derivative litigation history.

"Behind everything we do is the belief that companies should be governed responsibly, fiduciaries should be held accountable, and shareholders deserve transparency and fairness," said Brian J. Robbins, Founding Partner of Robbins LLP.

To be notified if a class action against Pentair plc settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:PNR

Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Robbins LLP Urges HDB Stockholders Who Lost Money Investing in HDFC Bank Limited to Contact the Firm for Information About Leading the Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired HDFC Bank Limited (NYSE: HDB) securities between July 17, 2023 and May 26, 2026 (the "Class Period"). HDFC is an Indian financial services conglomerate and banking company headquartered in Mumbai. The complaint alleges that HDFC Bank camouflaged payments as marketing spend to pay higher interest to a state f...

Robbins LLP Urges REPL Stockholders to Contact the Firm for Information About the Class Action Against Replimune Group, Inc.

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Replimune Group, Inc. (NASDAQ: REPL) securities between October 20, 2025 and April 10, 2026 ("Class Period"). Replimune purports to be a clinical-stage biotechnology company focused on novel oncolytic immunotherapies. According to the complaint, the Company’s lead product candidate is RP1 (vusolimogene oderp...

Stockholder Alert: Robbins LLP Informs Investors of the Hims & Hers Health, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--The complaint alleges that Hims shared customers' protected health information with advertisers and engaged in other deceptive advertising practices....
Back to Newsroom